Klotho Neurosciences, Inc.(KLTO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

KLTO Klotho Neurosciences, Inc.

Market Closed 03-13 16:00:00 EDT

0.5242

+0.0000

0.00%

High0.5242	Low0.5242	Vol0.00
Open0.5242	D1 Closing0.5242	Amplitude0.00%
Mkt Cap56.61M	Tradable Cap51.42M	Total Shares108.00M
T/O0.00	T/O Rate0.00%	Tradable Shares98.09M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"KLTO","market":"US","secType":"STK","nameCN":"Klotho Neurosciences, Inc.","latestPrice":0.5242,"timestamp":1773432000000,"preClose":0.5242,"halted":8,"volume":0,"delay":0,"changeRate":0,"floatShares":98090000,"shares":108000000,"eps":-0.304642,"marketStatus":"Market Closed","change":0,"latestTime":"03-13 16:00:00 EDT","open":0.5242,"high":0.5242,"low":0.5242,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.304642,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1773648000000},"marketStatusCode":7,"symbolChange":{"newSymbol":"GRML","executeDate":"2026-03-12"},"adr":0,"exchange":"NASDAQ","adjPreClose":0.5242,"volumeRatio":0},"requestUrl":"/m/hq/s/KLTO/tweets","defaultTab":"tweets","newsList":[{"id":"2618162687","title":"Klotho Neurosciences Announces Rebranding to Greenland Mines Ltd and Change of Nasdaq Ticker Symbol to Grml Effective March 12, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2618162687","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618162687?lang=en_us&edition=fundamental","pubTime":"2026-03-09 20:30","pubTimestamp":1773059411,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260309:nFWN3ZX10V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GRML","BK4139","KLTO"],"gpt_icon":0},{"id":"2616586205","title":"BRIEF-Klotho Neurosciences Acquires Greenland Mines Corp., Securing Control Of A $68 Billion Palladium, Gold, Platinum, And Critical Mineral Deposit In The World's Most Strategically Vital Emerging Trade Corridor","url":"https://stock-news.laohu8.com/highlight/detail?id=2616586205","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616586205?lang=en_us&edition=fundamental","pubTime":"2026-03-04 21:01","pubTimestamp":1772629318,"startTime":"0","endTime":"0","summary":"BRIEF-Klotho Neurosciences Acquires Greenland Mines Corp., Securing Control Of A $68 Billion Palladium, Gold, Platinum, And Critical Mineral Deposit In The World's Most Strategically Vital Emerging Tr","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260304:nTUA8J3YRK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KLTO"],"gpt_icon":0},{"id":"2616659558","title":"Klotho Neurosciences Inc - Company to Change Name and Stock Ticker in Late March 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2616659558","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616659558?lang=en_us&edition=fundamental","pubTime":"2026-03-04 21:00","pubTimestamp":1772629201,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260304:nTUA8J3YRK:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","KLTO"],"gpt_icon":0},{"id":"2616558560","title":"Klotho Neurosciences Acquires Greenland Mines Corp., Securing Control of a $68 Billion Palladium, Gold, Platinum, and Critical Mineral Deposit in the World's Most Strategically Vital Emerging Trade Corridor","url":"https://stock-news.laohu8.com/highlight/detail?id=2616558560","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616558560?lang=en_us&edition=fundamental","pubTime":"2026-03-04 21:00","pubTimestamp":1772629201,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260304:nTUA8J3YRK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KLTO","BK4139"],"gpt_icon":0},{"id":"2616558328","title":"Klotho Neurosciences Inc - Under Deal, Greenland Mines Corp. Expected to Own 93% of Fully Diluted Shares Outstanding","url":"https://stock-news.laohu8.com/highlight/detail?id=2616558328","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616558328?lang=en_us&edition=fundamental","pubTime":"2026-03-04 21:00","pubTimestamp":1772629201,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260304:nTUA8J3YRK:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KLTO","BK4139"],"gpt_icon":0},{"id":"2616364885","title":"Klotho Neurosciences Closes $7.75M Private Placement of Shares and Warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=2616364885","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616364885?lang=en_us&edition=fundamental","pubTime":"2026-03-03 06:04","pubTimestamp":1772489078,"startTime":"0","endTime":"0","summary":"Klotho Neurosciences, Inc. said it closed a private placement on March 2, 2026, issuing 34,551,939 shares of common stock and warrants to buy up to an additional 34,551,939 shares. The company reported gross proceeds of about $7.75 million, and said the unregistered offering relied on Section 4 and/or Rule 506 of Regulation D and was sold to accredited investors without general solicitation.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Klotho Neuroscience Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 02, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260302:nNDLbbjPFh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KLTO"],"gpt_icon":0},{"id":"2613935711","title":"Klotho Neurosciences launches AI-driven Klotho Clock to measure biological aging via epigenetics","url":"https://stock-news.laohu8.com/highlight/detail?id=2613935711","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613935711?lang=en_us&edition=fundamental","pubTime":"2026-02-24 21:00","pubTimestamp":1771938049,"startTime":"0","endTime":"0","summary":"Klotho Neurosciences said it has initiated development of two genomics-based diagnostic tests aimed at assessing biological aging and supporting its clinical trials and longevity services. The company is developing a blood-based quantitative DNA methylation assay to measure methylation of the alpha-Klotho gene, and an AI-enabled “Klotho Clock” that analyzes DNA and mRNA sequences of Klotho and eight other longevity-associated genes to help link biological and chronological age. The announcement describes ongoing development and a prototype expected in 2026; no research results were reported as already presented.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nNDLzRV8r:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KLTO"],"gpt_icon":0},{"id":"2613909757","title":"Klotho Neurosciences: Entered Into Securities Purchase Agreement, to Issue 34.6 Mln Shares - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2613909757","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613909757?lang=en_us&edition=fundamental","pubTime":"2026-02-24 19:03","pubTimestamp":1771930997,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nFWN3ZK0P4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","KLTO"],"gpt_icon":0},{"id":"2613790460","title":"Klotho Neurosciences Announces Private Placement of 34.55 Million Shares at $0.2243 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=2613790460","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613790460?lang=en_us&edition=fundamental","pubTime":"2026-02-24 19:02","pubTimestamp":1771930953,"startTime":"0","endTime":"0","summary":"Klotho Neurosciences Inc. said it entered into a securities purchase agreement with 10 investors to sell 34,551,939 shares of common stock at $0.2243 per share, based on the Nasdaq official closing price for the prior five trading days. The investors also received five-year warrants to buy an equal number of shares at $0.2243 per share, exercisable only after stockholder approval. The company expects the closing to occur on or before March 15, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Klotho Neuroscience Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 24, 2026, an","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nNDL11rpMd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KLTO"],"gpt_icon":0},{"id":"2612446329","title":"Klotho announces 18 claims within patent application in Australia for s-KL","url":"https://stock-news.laohu8.com/highlight/detail?id=2612446329","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612446329?lang=en_us&edition=fundamental","pubTime":"2026-02-18 21:10","pubTimestamp":1771420224,"startTime":"0","endTime":"0","summary":"Klotho Neurosciences (KLTO)announces the acceptance of 18 claims within a patent application filed in Australia for composition and use of human se...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/klotho-announces-18-claims-within-patent-application-in-australia-for-s-kl-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/klotho-announces-18-claims-within-patent-application-in-australia-for-s-kl-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KLTO","BK4139"],"gpt_icon":0},{"id":"2612445426","title":"Klotho Neurosciences Receives Patent Claims in Australia for Composition and Use of Human Secreted Klotho Protein (\"S-Kl\") Isoform of the Human Klotho Gene Sequence","url":"https://stock-news.laohu8.com/highlight/detail?id=2612445426","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612445426?lang=en_us&edition=fundamental","pubTime":"2026-02-18 21:06","pubTimestamp":1771419964,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260218:nFWN3ZD1GR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KLTO","BK4139"],"gpt_icon":0},{"id":"2612445147","title":"Klotho Neurosciences Wins Acceptance of 18 Australian Patent Claims for Secreted Klotho (s‑KL) Motor-Impairment Therapy Use","url":"https://stock-news.laohu8.com/highlight/detail?id=2612445147","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612445147?lang=en_us&edition=fundamental","pubTime":"2026-02-18 21:03","pubTimestamp":1771419808,"startTime":"0","endTime":"0","summary":"Klotho Neurosciences said IP Australia has accepted 18 claims in an Australian patent application covering the composition and use of the human secreted Klotho protein  isoform. The claims include using a muscle-cell specific promoter linked to an s-KL gene sequence to treat motor impairment, as well as delivery approaches involving neuronal cells, induced pluripotent stem cells, and viral or non-viral vectors with muscle-cell and/or motor neuron-cell tropism.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260218:nNDLb1rlFq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KLTO","BK4139"],"gpt_icon":0},{"id":"2612957524","title":"Klotho Neuroscience Inc. Held Special Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2612957524","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612957524?lang=en_us&edition=fundamental","pubTime":"2026-02-18 06:21","pubTimestamp":1771366882,"startTime":"0","endTime":"0","summary":"Klotho Neuroscience Inc. held a special meeting of stockholders on February 17, 2026. Stockholders approved an amendment to the certificate of incorporation to effect a reverse stock split at a ratio to be determined by the board of directors. An amendment to increase the number of shares available under the 2024 Equity Incentive Plan was also approved.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Klotho Neuroscience Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 17, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260217:nNDL5Q3dsL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KLTO","BK4139"],"gpt_icon":0},{"id":"2603525470","title":"Klotho Neuroscience Inc. Announces Date for Upcoming Special Stockholders Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2603525470","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603525470?lang=en_us&edition=fundamental","pubTime":"2026-01-13 04:49","pubTimestamp":1768250956,"startTime":"0","endTime":"0","summary":"Klotho Neurosciences, Inc. has announced that it will hold a special meeting of stockholders on February 13, 2026. The meeting will be conducted in a virtual format via Zoom videoconference. At the meeting, stockholders will be asked to approve certain matters as described in the company's proxy statement.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Klotho Neuroscience Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 12, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nNDL195gJw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KLTO","BK4139"],"gpt_icon":0},{"id":"2590036655","title":"Klotho Neuroscience Sells $15M in Series C Preferred Stock to Sigma9 Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2590036655","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590036655?lang=en_us&edition=fundamental","pubTime":"2025-12-09 05:32","pubTimestamp":1765229545,"startTime":"0","endTime":"0","summary":"Klotho Neuroscience Inc. has announced it has entered into a Securities Purchase Agreement with Sigma9 Capital, Ltd. for a private placement of 3,400 shares of its newly designated Series C Preferred Stock at $4,400 per share. The transaction, which is an unregistered sale conducted under Section 4 of the Securities Act of 1933, is subject to closing conditions including the filing of a Certificate of Designation and completion by December 31, 2025. Each share of Series C Preferred Stock will be convertible into 10,000 shares of common stock, subject to certain ownership and regulatory limitations. No underwriters or sales commissions were involved in the transaction.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Klotho Neuroscience I","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251208:nNDL6tljZ2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KLTO","BK4139"],"gpt_icon":0},{"id":"2589884899","title":"Klotho Neurosciences Inc -  Files Prospectus for Offer and Resale by Selling Stockholders of up to 34.9 Mln Shares of Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2589884899","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589884899?lang=en_us&edition=fundamental","pubTime":"2025-12-06 06:19","pubTimestamp":1764973170,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251205:nFWN3XB131:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KLTO","BK4139"],"gpt_icon":0},{"id":"2583481495","title":"Klotho Neurosciences Q3 EPS $(0.05) Up From $(0.18) YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2583481495","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583481495?lang=en_us&edition=fundamental","pubTime":"2025-11-14 06:42","pubTimestamp":1763073767,"startTime":"0","endTime":"0","summary":"Klotho Neurosciences (NASDAQ:KLTO) reported quarterly losses of $(0.05) per share. This is a 72.22 percent increase over losses of $(0.18) per share from the same period last year.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/11/48853426/klotho-neurosciences-q3-eps-0-05-up-from-0-18-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":[".IXIC","KLTO","QLD","MNQmain","PSQ","SQQQ","NQmain","TSYW.SI","TQQQ","USAW.SI","NVIW.SI","QID","USJW.SI","BK4139"],"gpt_icon":0},{"id":"2573991727","title":"Klotho and Turn allow Letter of Intent to expire","url":"https://stock-news.laohu8.com/highlight/detail?id=2573991727","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573991727?lang=en_us&edition=fundamental","pubTime":"2025-10-08 06:25","pubTimestamp":1759875909,"startTime":"0","endTime":"0","summary":"Klotho Neurosciences (KLTO)announced that its Letter of Intent, or LoI, with Turn Biotechnologies was allowed to expire by the parties. Following c...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/klotho-and-turn-allow-letter-of-intent-to-expire-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/klotho-and-turn-allow-letter-of-intent-to-expire-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KLTO","BK4139"],"gpt_icon":0},{"id":"2573599193","title":"BRIEF-Klotho Neurosciences Announces Expiration Of Letter Of Intent","url":"https://stock-news.laohu8.com/highlight/detail?id=2573599193","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573599193?lang=en_us&edition=fundamental","pubTime":"2025-10-08 06:22","pubTimestamp":1759875734,"startTime":"0","endTime":"0","summary":"BRIEF-Klotho Neurosciences Announces Expiration Of Letter Of IntentOct 7 (Reuters) - Klotho Neurosciences Inc KLTO.O:KLOTHO NEUROSCIENCES ANNOUNCES EXPIRATION OF LETTER OF INTENTKLOTHO NEUROSCIENCES I","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251007:nFWN3VO2N2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KLTO"],"gpt_icon":0},{"id":"2573991697","title":"Klotho Neurosciences Inc: Loi With Turn Biotechnologies Allowed to Expire by Parties","url":"https://stock-news.laohu8.com/highlight/detail?id=2573991697","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573991697?lang=en_us&edition=fundamental","pubTime":"2025-10-08 06:21","pubTimestamp":1759875668,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251007:nFWN3VO2N2:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KLTO","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.klothoneuro.com","stockEarnings":[{"period":"1week","weight":0.143},{"period":"1month","weight":1.2732},{"period":"3month","weight":0.3092},{"period":"6month","weight":-0.1118},{"period":"1year","weight":0.8721},{"period":"ytd","weight":0.8138}],"compareEarnings":[{"period":"1week","weight":-0.015},{"period":"1month","weight":-0.0429},{"period":"3month","weight":-0.0286},{"period":"6month","weight":0.0074},{"period":"1year","weight":0.2011},{"period":"ytd","weight":-0.0288}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Klotho Neurosciences, Inc., a biopharmaceutical company, develops therapies for neurological and age-related disorders, and specialty diagnostics. Its products include cell and gene therapies to mitigate age-related pathologies, such as dementia symptoms, and Alzheimer and neuromuscular diseases; biologics/biosimilars in the treatment of cancer; and melanocortin receptors. The company has a strategic partnership with Japan's Okinawa Research Center for the research and development of Klotho gene therapy in enhancing longevity and reducing age-related diseases. The company was formerly known as Anew Medical, Inc. and changed its name to Klotho Neurosciences, Inc. in September 2024. Klotho Neurosciences, Inc. is based in Omaha, Nebraska.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.06215},{"month":2,"riseRate":0.5,"avgChangeRate":0.188375},{"month":3,"riseRate":0.5,"avgChangeRate":-0.036461},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.218192},{"month":5,"riseRate":0.5,"avgChangeRate":-0.006199},{"month":6,"riseRate":0.75,"avgChangeRate":1.150026},{"month":7,"riseRate":0.25,"avgChangeRate":-0.147403},{"month":8,"riseRate":0.25,"avgChangeRate":-0.147672},{"month":9,"riseRate":0.5,"avgChangeRate":-0.1464},{"month":10,"riseRate":0.5,"avgChangeRate":-0.038644},{"month":11,"riseRate":0.25,"avgChangeRate":-0.077658},{"month":12,"riseRate":0.5,"avgChangeRate":-0.032823}],"exchange":"NASDAQ","name":"Klotho Neurosciences, Inc.","nameEN":"Klotho Neurosciences, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Klotho Neurosciences, Inc.(KLTO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Klotho Neurosciences, Inc.(KLTO) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Klotho Neurosciences, Inc.,KLTO,Klotho Neurosciences, Inc.股票,Klotho Neurosciences, Inc.股票老虎,Klotho Neurosciences, Inc.股票老虎国际,Klotho Neurosciences, Inc.行情,Klotho Neurosciences, Inc.股票行情,Klotho Neurosciences, Inc.股价,Klotho Neurosciences, Inc.股市,Klotho Neurosciences, Inc.股票价格,Klotho Neurosciences, Inc.股票交易,Klotho Neurosciences, Inc.股票购买,Klotho Neurosciences, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Klotho Neurosciences, Inc.(KLTO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Klotho Neurosciences, Inc.(KLTO) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction